Forte Biosciences (FBRX) Competitors $19.34 +0.68 (+3.64%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends FBRX vs. TARA, LPTX, XFOR, MGX, ADVM, JMAC, INMB, CRDL, DERM, and IPSCShould you be buying Forte Biosciences stock or one of its competitors? The main competitors of Forte Biosciences include Protara Therapeutics (TARA), Leap Therapeutics (LPTX), X4 Pharmaceuticals (XFOR), Metagenomi (MGX), Adverum Biotechnologies (ADVM), Maxpro Capital Acquisition (JMAC), INmune Bio (INMB), Cardiol Therapeutics (CRDL), Journey Medical (DERM), and Century Therapeutics (IPSC). These companies are all part of the "pharmaceutical products" industry. Forte Biosciences vs. Protara Therapeutics Leap Therapeutics X4 Pharmaceuticals Metagenomi Adverum Biotechnologies Maxpro Capital Acquisition INmune Bio Cardiol Therapeutics Journey Medical Century Therapeutics Protara Therapeutics (NASDAQ:TARA) and Forte Biosciences (NASDAQ:FBRX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, community ranking, earnings, valuation and risk. Do insiders and institutionals have more ownership in TARA or FBRX? 38.1% of Protara Therapeutics shares are held by institutional investors. Comparatively, 77.6% of Forte Biosciences shares are held by institutional investors. 12.5% of Protara Therapeutics shares are held by insiders. Comparatively, 9.6% of Forte Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor TARA or FBRX? In the previous week, Forte Biosciences' average media sentiment score of 0.00 beat Protara Therapeutics' score of -0.12 indicating that Forte Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Protara Therapeutics Neutral Forte Biosciences Neutral Does the MarketBeat Community prefer TARA or FBRX? Protara Therapeutics received 7 more outperform votes than Forte Biosciences when rated by MarketBeat users. Likewise, 66.67% of users gave Protara Therapeutics an outperform vote while only 60.42% of users gave Forte Biosciences an outperform vote. CompanyUnderperformOutperformProtara TherapeuticsOutperform Votes3666.67% Underperform Votes1833.33% Forte BiosciencesOutperform Votes2960.42% Underperform Votes1939.58% Which has more risk & volatility, TARA or FBRX? Protara Therapeutics has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500. Comparatively, Forte Biosciences has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Do analysts rate TARA or FBRX? Protara Therapeutics currently has a consensus price target of $22.67, suggesting a potential upside of 320.53%. Forte Biosciences has a consensus price target of $23.58, suggesting a potential upside of 21.94%. Given Protara Therapeutics' higher possible upside, equities research analysts plainly believe Protara Therapeutics is more favorable than Forte Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Protara Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Forte Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, TARA or FBRX? Protara Therapeutics is trading at a lower price-to-earnings ratio than Forte Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProtara TherapeuticsN/AN/A-$40.42M-$2.82-1.91Forte BiosciencesN/AN/A-$31.48M-$16.29-1.19 Is TARA or FBRX more profitable? Protara Therapeutics' return on equity of -55.96% beat Forte Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Protara TherapeuticsN/A -55.96% -49.06% Forte Biosciences N/A -151.43%-118.92% SummaryProtara Therapeutics beats Forte Biosciences on 8 of the 12 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBRX vs. The Competition Export to ExcelMetricForte BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.28M$6.57B$5.12B$9.07BDividend YieldN/A2.98%4.91%4.22%P/E Ratio-1.1910.5991.3417.19Price / SalesN/A195.381,116.59116.80Price / CashN/A57.1642.6437.86Price / Book0.805.104.794.78Net Income-$31.48M$151.51M$120.07M$225.60M7 Day Performance-16.46%-2.15%-1.89%-1.24%1 Month Performance24.37%-3.14%11.45%3.36%1 Year PerformanceN/A11.50%30.61%16.58% Forte Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBRXForte Biosciences1.6851 of 5 stars$19.34+3.6%$23.58+21.9%+65,237.8%$28.28MN/A-1.195TARAProtara Therapeutics2.3557 of 5 stars$5.76-3.7%$22.67+293.5%+196.2%$118.83MN/A-2.1230LPTXLeap Therapeutics1.2971 of 5 stars$3.06+3.7%$7.50+145.1%-1.0%$117.26M$1.50M-1.5340Positive NewsGap DownXFORX4 Pharmaceuticals4.3223 of 5 stars$0.68+1.5%$3.50+414.7%-16.4%$115.97MN/A-8.2280Gap DownMGXMetagenomi2.1336 of 5 stars$3.00-7.4%$16.67+455.6%N/A$112.27M$55.08M0.00236High Trading VolumeADVMAdverum Biotechnologies4.215 of 5 stars$5.39+0.4%$27.83+416.4%-40.0%$112.12M$1M-0.90190Analyst DowngradeNews CoverageJMACMaxpro Capital AcquisitionN/A$8.34+7.8%N/A+837.6%$112.00MN/A0.002,021Gap DownINMBINmune Bio1.4934 of 5 stars$4.99+5.1%$20.00+300.8%-55.7%$110.64M$42,000.00-2.1810CRDLCardiol Therapeutics2.2494 of 5 stars$1.35+1.5%$8.75+548.5%+44.0%$110.24M$60,000.00-3.4120Analyst ForecastAnalyst RevisionNews CoverageGap DownDERMJourney Medical2.5549 of 5 stars$5.12+0.6%$9.38+83.1%N/A$106.96M$79.18M-5.4190IPSCCentury Therapeutics1.8221 of 5 stars$1.25+2.5%$11.60+828.0%-52.6%$106.29M$2.68M-0.66170High Trading Volume Related Companies and Tools Related Companies TARA Competitors LPTX Competitors XFOR Competitors MGX Competitors ADVM Competitors JMAC Competitors INMB Competitors CRDL Competitors DERM Competitors IPSC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FBRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forte Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FBRX Stock Alerts